A gold nanoparticle (AuNP) has a
localized surface plasmon resonance peak depending on its size, which
is often utilized for surface-enhanced Raman scattering (SERS). To
obtain information on the cholesterol (Chol)-incorporated lipid membranes
by SERS, AuNPs (5, 100 nm) were first functionalized by 1-octanethiol
and then modified by lipids (AuNP@lipid). In membrane surface-enhanced
Raman spectroscopy (MSERS), both signals from 1,2-dioleoyl-
sn
-glycero-3-phosphocholine (DOPC) and Chol molecules were
enhanced, depending on preparation conditions (size of AuNPs and lipid/AuNP
ratio). The enhancement factors (EFs) were calculated to estimate
the efficiency of AuNPs on Raman enhancement. The size of AuNP
100nm
@lipid was 152.0 ± 12.8 nm, which showed an surface
enhancement Raman spectrum with an EF
2850
value of 111
± 9. The size of AuNP
5nm
@lipid prepared with a lipid/AuNP
ratio of 1.38 × 10
4
(lipid molecule/particle) was
275.3 ± 20.2 nm, which showed the highest enhancement with an
EF
2850
value of 131 ± 21. On the basis of fluorescent
probe analyses, the membrane fluidity and polarity of AuNP@lipid were
almost similar to DOPC/Chol liposome, indicating an intact membrane
of DOPC/Chol after modification with AuNPs. Finally, the membrane
properties of AuNP@lipid systems were also discussed on the basis
of the obtained MSERS signals.
The synthesis of silver nanoparticles (Ag-NPs) was achieved by a simple green chemistry procedure using sodium alginate (Na-Alg) under ultrasonic radiation as a stabilizer and physical reducing agent. The effect of radiation time on the synthesis of Ag-NPs was carried out at room temperature until 720 min. The successful formation of Ag-NPs has been confirmed by UV-Vis, XRD, TEM, FESEM-EDX, zeta potential, and FT-IR analyses. The surface plasmon resonance band appeared at the range of 452–465 nm that is an evidence of formation of Ag-NPs. The XRD study showed that the particles are crystalline structure in nature, with a face-centered cubic (fcc) structure. The TEM study showed the Ag-NPs have average diameters of around 20.16–22.38 nm with spherical shape. The FESEM-EDX analysis confirmed the spherical shape of Ag-NPs on the surface of Alg and the element of Ag with the high purity. The zeta potential showed high stability of Alg/Ag-NPs especially after 720 min irradiation with value of −67.56 mV. The FT-IR spectrum confirmed that the Ag-NPs have been capped by the Alg with van der Waals interaction. The Alg/Ag-NPs showed the antibacterial activity against Gram-positive and Gram-negative bacteria. These suggest that Ag-NPs can be employed as an effective bacteria inhibitor and can be applied in medical field.
Amyloid β (Aβ) is a potential biomarker of Alzheimer's disease (AD), and its fibrillation behavior is of interest and value. In this study, the Aβ behaviors on phospholipid membranes were observed by Membrane Surface-Enhanced Raman Spectroscopy (MSERS) method. Phospholipid (PL) membranes, consisting of DMPC and DMPS with a molar ratio of 9:1, were fabricated on gold nanoparticles with diameter of 100 nm (Au@PL). Enhancement of the Raman intensity of Au@PL was increased by Aβ, with enhancement factor about 40. The H-bonding network was disturbed in presence of NaCl which covered Au@PL and made Au@PL away from one another. When Aβ was applied with Au@PL, the H-bonding network was disturbed just after mixing. As the reaction reaches to equilibrium, Aβ attracted neighbouring Au@PL and induced aggregation of Au@PL which blocked the aggregation prone site of Aβ to inhibit further fibrillation. Based on our method, the Aβ behaviors at lipid membrane surface can be directly observed via enhanced Raman signals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.